The June 27 cyber attack has not affected production of public joint-stock company Farmak (Kyiv), the largest pharmaceutical manufacturer in Ukraine, the company has reported on its website.

"The cyber attack did not affect production processes. The company continues operating as usual," the company said.

The company said that its IT service cooperates with leading vendors and cyber security exerts. The company takes measures to prevent these attacks.

The Arterium pharmaceutical corporation told Interfax-Ukraine that some difficulties are seen now over the cyber attack.

"Our specialists are settling them," the corporation said.

According to media reports, the Borys clinic and Feofaniya hospital suffered from the virus.

Farmak is a large pharmaceutical company in Ukraine with the share of total sales in the country in money terms of around 6.5%. The company has 19 production lines meeting GMP requirements.

Farmak produces 220 different medicines.

Annually Farmak brings up to 20 new products to the market. Its products are exported to 20 countries.

Arterium Corporation includes the Kyivmedpreparat manufacturer of antibiotics and Lviv-based Galychpharm, a leader in the production of plant-based drugs.